| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |